Elsevier

Preventive Medicine

Volume 65, August 2014, Pages 99-102
Preventive Medicine

Brief Original Report
Determinants of use of smoking cessation aids in 27 European countries

https://doi.org/10.1016/j.ypmed.2014.05.004Get rights and content

Highlights

  • We analysed data from the 2012 Eurobarometer survey, from 27 European countries.

  • 19.9% of ex/current smokers who tried to quit have used efficacious cessation aids.

  • Use of aids was more likely among Northern compared to Southern Europeans.

  • Use of recommended aids was more likely in countries which fund cessation programmes.

  • No socioeconomic or educational differences in the use of aids were identified.

Abstract

Objective

To identify determinants of use of smoking cessation aids among current and former smokers in the European Union (EU).

Methods

Data from n = 9921 current and ex-smokers from 27 European countries (Eurobarometer 77.1, February–March 2012) were analysed. Multivariate binary logistic regression was used to assess for correlates of use of any recommended aid with proven efficacy, defined as use of pharmacotherapy or psychosocial counselling (p < 0.05). The regression analyses assessed for socio-demographic characteristics, EU region, as well as scope of national smoking cessation policies.

Results

Among current smokers who had made a quit attempt and ex-smokers, 19.9% had used any recommended aid with proven efficacy. Respondents from Northern (adjusted odds ratio [aOR] = 1.90), Western (aOR = 3.21) and Eastern Europe (aOR = 1.69) were more likely to have used an efficacious smoking cessation aid compared to respondents from Southern Europe (all p < 0.05). Respondents in countries with comprehensive tobacco cessation programmes that offered cost-covered national quit lines, medication, and other cessation services had increased likelihood of using efficacious cessation aids (OR = 1.29; 95% Confidence Interval: 1.07–1.55).

Conclusions

These findings underscore the need for enhanced and sustained efforts to ensure increased access to cessation services and aids as part of a comprehensive tobacco control programme.

Introduction

Smoking cessation is one of the main strategies suggested by the World Health Organization's (WHO) MPOWER package against the tobacco epidemic (World Health Organization, 2008). The majority of smokers who make a quit attempt, do so without assistance (Cokkinides et al., 2005, Ismailov and Leatherdale, 2010, Rutqvist, 2012), even though several cessation aids, such as medication and provision or referral for counselling, have been proven highly effective (Cahill et al., 2013, Stead et al., 2012, Stead et al., 2013a, Stead et al., 2013b) and are recommended by organisations like the United Kingdom National Health Service (NHS, 2008) and the U.S. Public Health Service Guidelines for tobacco dependence treatment (Tobacco Use and Dependence Guideline Panel, 2008). Other aids are also available, even though evidence of their effectiveness on long-term cessation remains inconclusive (Bullen et al., 2013, White et al., 2014). Smoking cessation and quit attempts have been associated with gender, socioeconomic status, age and employment (Bacigalupe et al., 2013, Davila et al., 2009, Kaleta et al., 2012). However, European-wide research on the determinants of cessation aids' use has been limited (Ismailov and Leatherdale, 2010, Messer et al., 2008, Rutqvist, 2012). Hence, the objective of this study was to assess determinants of smoking cessation aids' use among current and former smokers in the European Union (EU).

Section snippets

Methods

We analysed publicly available data from the Eurobarometer survey, wave 77.1 (February–March 2012) (n = 26,751) (European Commission, 2012a). The survey was conducted in the 27 European Union member countries and included respondents aged ≥ 15 years. Nationally representative samples of persons aged ≥ 15 years were selected through a multi-stage sampling design in each of the 27 EU member countries. Interviews were conducted in people's homes and in the language of each country.

Smoking status was

Results

In total, 9921 respondents were either current smokers who had made a quit attempt (n = 4341) or former smokers (n = 5580). Overall, 32.2% reported using “any smoking cessation aid” (from 16.4% in Greece to 45.9% in Sweden), while 19.9% reported using “any recommended aid with proven efficacy” (from 6.4% in Greece to 41.4% in Ireland) (Table 1, Fig. 1). NRT and other medications were the most popular smoking cessation aids (14.6%), followed by health professional support (6.7%). Wide

Discussion

Our findings demonstrated that the use of smoking cessation aids varied greatly between countries and regions within the EU, whereas age was the only individual-level factor that was a significant determinant of cessation aid use. Extensive coverage/availability of cessation services was also associated with the use of aids of proven efficacy.

Current and former smokers in Southern European countries were less likely to have used smoking cessation aids. This might reflect regional variations in

Conclusions

The likelihood of using smoking cessation aids was higher among Northern European current and former smokers compared to other EU areas, especially Southern Europe. In addition, smokers in countries with comprehensive national cessation programmes had an increased likelihood of using an efficacious smoking cessation aid. These findings underscore the need for enhanced and sustained efforts to improve health systems and to ensure increased access to cessation services and aids as part of a

Conflict of interest statement

The authors declare that there are no conflicts of interest.

References (25)

  • European Commission

    Eurobarometer 385. Attitudes of Europeans towards tobacco

  • D. Kaleta et al.

    Predictors of long-term smoking cessation: results from the global adult tobacco survey in Poland (2009–2010)

    BMC Public Health

    (2012)
  • Cited by (0)

    View full text